These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 2186418)
1. Biochemical strategies in the search for cognition enhancers. Briley M Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():75-80. PubMed ID: 2186418 [TBL] [Abstract][Full Text] [Related]
2. Psychopharmacological strategies in the search for cognition enhancers. Sanger DJ; Joly D Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():70-4. PubMed ID: 2186417 [TBL] [Abstract][Full Text] [Related]
3. Biochemical models for cognition enhancers. Costall B; Barnes JM; Hamon M; Müller WE; Briley M Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():85-8; discussion 89. PubMed ID: 2186420 [TBL] [Abstract][Full Text] [Related]
4. The development of behavioral tests to assess the effects of cognitive enhancers. Olton DS; Wenk L Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():65-9. PubMed ID: 2186416 [TBL] [Abstract][Full Text] [Related]
9. Effects of oestrogen on cognition: what have we learned from basic research? Daniel JM J Neuroendocrinol; 2006 Oct; 18(10):787-95. PubMed ID: 16965297 [TBL] [Abstract][Full Text] [Related]
11. Neuropharmacology of cognition and memory: a unifying theory of neuromodulator imbalance in psychiatry and amnesia. Vakalopoulos C Med Hypotheses; 2006; 66(2):394-431. PubMed ID: 16300905 [TBL] [Abstract][Full Text] [Related]
12. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach. Davidson M; Stern RG Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728 [TBL] [Abstract][Full Text] [Related]
13. Glutamatergic systems in Alzheimer's disease. Francis PT Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S15-21. PubMed ID: 12973746 [TBL] [Abstract][Full Text] [Related]
14. Pregnenolone sulfate and aging of cognitive functions: behavioral, neurochemical, and morphological investigations. Mayo W; Le Moal M; Abrous DN Horm Behav; 2001 Sep; 40(2):215-7. PubMed ID: 11534985 [TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement. Brousseau G; Rourke BP; Burke B Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307 [TBL] [Abstract][Full Text] [Related]
16. [Viewpoint on the methodology of drug trials affecting cognition of elderly patients]. Allain H; Bernard PM; Dartigues JF; Dérouesné C; Dubois B; Hugonot L; Laurent B; Léger JM; Malauzat D; Michel B Encephale; 1994; 20(6):725-39. PubMed ID: 7875107 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological models for the study of cognition enhancers. Delacour J; Bassant MH; Onofrj M; Santucci V; Kleinlogel H Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():90-3. PubMed ID: 2186421 [TBL] [Abstract][Full Text] [Related]